Galectin-10, a potential biomarker of eosinophilic airway inflammation

Justin Chua; Jo A Douglass; Andrew Gillman; Robyn E O'Hehir; Els Nicole Theresia Meeusen

doi:10.1371/journal.pone.0042549

Galectin-10, a potential biomarker of eosinophilic airway inflammation

Justin Chua, Jo A Douglass, Andrew Gillman, Robyn E O'Hehir, Els Nicole Theresia Meeusen

Research output: Contribution to journal › Article › Research › peer-review

39 Citations (Scopus)

Abstract

Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.

Original language	English
Article number	e42549
Number of pages	6
Journal	PLoS ONE
Volume	7
Issue number	8
DOIs	https://doi.org/10.1371/journal.pone.0042549
Publication status	Published - 2012

Access to Document

10.1371/journal.pone.0042549Licence: CC BY

2237051-oaFinal published version, 871 KBLicence: CC BY

Cite this

@article{7d8c15a8e1b74843a02b8cd1b353fe21,

title = "Galectin-10, a potential biomarker of eosinophilic airway inflammation",

abstract = "Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.",

author = "Justin Chua and Douglass, {Jo A} and Andrew Gillman and O'Hehir, {Robyn E} and Meeusen, {Els Nicole Theresia}",

year = "2012",

doi = "10.1371/journal.pone.0042549",

language = "English",

volume = "7",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science (PLoS)",

number = "8",

}

TY - JOUR

T1 - Galectin-10, a potential biomarker of eosinophilic airway inflammation

AU - Chua, Justin

AU - Douglass, Jo A

AU - Gillman, Andrew

AU - O'Hehir, Robyn E

AU - Meeusen, Els Nicole Theresia

PY - 2012

Y1 - 2012

N2 - Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.

AB - Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.

UR - http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042549

U2 - 10.1371/journal.pone.0042549

DO - 10.1371/journal.pone.0042549

M3 - Article

VL - 7

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 8

M1 - e42549

ER -

Galectin-10, a potential biomarker of eosinophilic airway inflammation

Abstract

Access to Document

Other files and links

Cite this